Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. News
Walgreens Boots Alliance, Inc. Quantitative Score
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Walgreens Boots Alliance, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Walgreens Boots Alliance, Inc. Financials
Table Compare
Compare WBA metrics with: | |||
|---|---|---|---|
Earnings & Growth | WBA | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | WBA | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | WBA | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | WBA | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Walgreens Boots Alliance, Inc. Income
Walgreens Boots Alliance, Inc. Balance Sheet
Walgreens Boots Alliance, Inc. Cash Flow
Walgreens Boots Alliance, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Walgreens Boots Alliance, Inc. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 1.0000 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2024-12-12 | 0.25 | Quarterly |
| 2024-09-12 | 0.25 | Quarterly |
| 2024-06-12 | 0.25 | Quarterly |
| 2024-03-12 | 0.25 | Quarterly |
| 2023-12-12 | 0.48 | Quarterly |
Historical Market Cap
Shares Outstanding
Walgreens Boots Alliance, Inc. Executives
| Name | Role |
|---|---|
| Mr. Manmohan Mahajan | Executive Vice President & Global Chief Financial Officer |
| Ms. Mary Langowski | Executive Vice President & President of Walgreens Health |
| Mr. Timothy C. Wentworth | Chief Executive Officer & Director |
| Ms. Ornella Barra | Chief Operating Officer of International |
| Mr. Stefano Pessina | Executive Chairman of the Board |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Manmohan Mahajan | Executive Vice President & Global Chief Financial Officer | Male | 1980 | 2.62M |
| Ms. Mary Langowski | Executive Vice President & President of Walgreens Health | Female | 1978 | 2.49M |
| Mr. Timothy C. Wentworth | Chief Executive Officer & Director | Male | 1960 | 1.9M |
| Ms. Ornella Barra | Chief Operating Officer of International | Female | 1953 | 1.5M |
| Mr. Stefano Pessina | Executive Chairman of the Board | Male | 1941 | 135.08K |
Walgreens Boots Alliance, Inc. Insider Trades
| Date | 9 Jul |
| Name | Huffines Robert Luther |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 2158.89 |
| Date | 9 Jul |
| Name | JARRETT VALERIE B |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 2590.67 |
| Date | 9 Jul |
| Name | Lederer John Anthony |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 2590.67 |
| Date | 1 Jun |
| Name | Minnix Lanesha |
| Role | EVP, Global CLO & Corp. Sec. |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 19135 |
| Date | 1 Jun |
| Name | Langowksi Mary |
| Role | EVP, President U.S. Healthcare |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 40304 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 9 Jul | Huffines Robert Luther | Director | Acquired | A-Award | 2158.89 |
| 9 Jul | JARRETT VALERIE B | Director | Acquired | A-Award | 2590.67 |
| 9 Jul | Lederer John Anthony | Director | Acquired | A-Award | 2590.67 |
| 1 Jun | Minnix Lanesha | EVP, Global CLO & Corp. Sec. | Disposed | F-InKind | 19135 |
| 1 Jun | Langowksi Mary | EVP, President U.S. Healthcare | Disposed | F-InKind | 40304 |